Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Ruggero Ponz de Leon Pisani

Matched on ORCID iD 0000-0002-6178-0659; OpenAlex author ID A5003425523. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 5 papers · 2026: 1 paper

Papers 10

  1. Paired Duodenal and Salivary Microbiome Analysis in Pancreatic Cancer Without Duct Obstruction. Co-author DOI 10.1002/ueg2.70179↗
  2. Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer. Co-author DOI 10.1016/j.dld.2024.05.017↗
  3. Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Co-author DOI 10.1016/j.dld.2025.03.009↗
  4. Author's reply: "Comment on "Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Co-author DOI 10.1016/j.dld.2025.08.085↗
  5. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  6. Gastrointestinal symptoms in the journey of pancreatic cancer patients. Co-author DOI 10.1080/14737140.2025.2517888↗
  7. Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery. Co-author DOI 10.1097/sla.0000000000006094↗
  8. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarc… Co-author DOI 10.1093/carcin/bgad056↗
  9. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  10. Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management. First author DOI 10.3390/cancers14246130↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gabriele Capurso · 7 shared papers, 2022–2026 · strength 1.68
  2. Paolo Giorgio Arcidiacono · 7 shared papers, 2022–2026 · strength 1.68
  3. Massimo Falconi · 6 shared papers, 2022–2026 · strength 1.25
  4. Lívia Archibugi · 6 shared papers, 2022–2026 · strength 1.20
  5. Michele Reni · 3 shared papers, 2025–2026 · strength 0.69
  6. Maria Chiara Petrone · 3 shared papers, 2022–2026 · strength 0.60
  7. Gemma Rossi · 2 shared papers, 2025–2026 · strength 0.44
  8. Giuseppe Vanella · 2 shared papers, 2025 · strength 0.44
  9. Matteo Tacelli · 2 shared papers, 2025 · strength 0.41
  10. Gaetano Lauri · 2 shared papers, 2025 · strength 0.41
  11. Giovanni Marchegiani · 1 shared paper, 2025 · strength 0.23
  12. Stefano Crippa · 1 shared paper, 2025 · strength 0.23
  13. Neil Daniel · 1 shared paper, 2025 · strength 0.20
  14. Annalisa Comandatore · 1 shared paper, 2025 · strength 0.20
  15. Riccardo Farinella · 1 shared paper, 2025 · strength 0.20
  16. Ľudmila Vodičková · 1 shared paper, 2025 · strength 0.20
  17. David J. Hughes · 1 shared paper, 2025 · strength 0.20
  18. Pavel Vodička · 1 shared paper, 2025 · strength 0.20
  19. Giulia Peduzzi · 1 shared paper, 2025 · strength 0.20
  20. Daniele Campa · 1 shared paper, 2025 · strength 0.20
  21. Stefano Landi · 1 shared paper, 2025 · strength 0.20
  22. Pinar Uysal Onganer · 1 shared paper, 2025 · strength 0.20
  23. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.20
  24. Juan Sáinz · 1 shared paper, 2025 · strength 0.20
  25. Marina Macchini · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.